Johnson & Johnson Vision’s iDESIGN Refractive Studio LASIK platform has been approved by the FDA, according to a press release.
The iDESIGN, which uses topography-integrated, wavefront-guided technology, allows physicians to take precise measurements of both the inside and outside of the eye to personalize the LASIK procedure to each patient, the release said.
It has been approved for myopia, hyperopia and mixed astigmatism, and is the only LASIK platform for monovision LASIK in presbyopic myopia.
“The new iDESIGN Refractive Studio provides surgeons with the ability to deliver
Uncategorized